Profil
Roger W.
Brimblecombe is currently a Director at 2gether NHS Foundation Trust.
He previously held Chairman positions at CeNeS Pharmaceuticals Plc, Vanguard Medica Plc, Oxford Asymmetry International Plc, EyePoint Pharmaceuticals, Inc., and Core Group Ltd. He was also a Director at Vertex Pharmaceuticals, Inc. for 17 years.
Brimblecombe has a graduate and doctorate degree from the University of Bristol.
Postes actifs de Roger W. Brimblecombe
| Sociétés | Poste | Début |
|---|---|---|
2gether NHS Foundation Trust
2gether NHS Foundation Trust Medical/Nursing ServicesHealth Services Provides health care services | Directeur/Membre du Conseil | 27/05/2009 |
Anciens postes connus de Roger W. Brimblecombe
| Sociétés | Poste | Fin |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Directeur/Membre du Conseil | 13/05/2010 |
Tissue Science Laboratories Ltd.
Tissue Science Laboratories Ltd. Medical SpecialtiesHealth Technology Develops and markets tissue implant products | Directeur/Membre du Conseil | 01/05/2008 |
| EYEPOINT, INC. | Président | 01/01/2007 |
Vertex Pharmaceuticals (Europe) Ltd.
Vertex Pharmaceuticals (Europe) Ltd. Medical DistributorsDistribution Services Supplies pharmaceutical products | Directeur/Membre du Conseil | 02/01/2005 |
Oxford Asymmetry International Plc
Oxford Asymmetry International Plc Chemicals: SpecialtyProcess Industries Specializes in the discovery and development of new drugs | Président | 01/01/2000 |
Formation de Roger W. Brimblecombe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
CeNeS Pharmaceuticals Plc
CeNeS Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the discovery and development of drugs | Health Technology |
Vanguard Medica Plc
Vanguard Medica Plc Miscellaneous Commercial ServicesCommercial Services Provides research and development in neosciences | Commercial Services |
Tissue Science Laboratories Ltd.
Tissue Science Laboratories Ltd. Medical SpecialtiesHealth Technology Develops and markets tissue implant products | Health Technology |
Oxford Asymmetry International Plc
Oxford Asymmetry International Plc Chemicals: SpecialtyProcess Industries Specializes in the discovery and development of new drugs | Process Industries |
EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
University of Bristol
University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vertex Pharmaceuticals (Europe) Ltd.
Vertex Pharmaceuticals (Europe) Ltd. Medical DistributorsDistribution Services Supplies pharmaceutical products | Distribution Services |
Core Group Ltd.
Core Group Ltd. Finance/Rental/LeasingFinance Provides construction equipment rental services | Finance |
Smithkline & French Laboratories US, Inc. | |
2gether NHS Foundation Trust
2gether NHS Foundation Trust Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
















